DIGESTIVE FORMULA
Natural health product licensed in Canada
- Other names
- Nu-Digest
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80049213
- Status
- Active licence
- Licence date
- 13 March 2014
- Revision date
- 18 October 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Aspergillus niger - En entier Potency : 60 FCC LU | 0.6 mg | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière Potency : 750 FCC PC | 7.5 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma reesei - en entier Potency : 6 XU | 6 mg | Not calculated |
| Glycyrrhiza glabra Source : Root (standardized extract) Potency : 1 % Glycyrrhizic acid | 33 mg | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus niger - En entier Potency : 7.5 Endo-PG | 1.5 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier Potency : 60 FCC CU | 0.6 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 9,000 FCC HUT | 18 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier Potency : 9 FCC AGU | 9 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, farine de riz, Stéarate de magnésium, Maltodextrine, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme. Digestive aid. Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80049213
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging